Breaking News

Vectalys, Flashcell Merge to Form New Gene Therapy Company

Flash Therapeutics to develop RNA-based therapeutics and provide broad lentiviral development and manufacturing services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Vectalys, a biotech company specialized in manufacturing lentiviral solutions for gene delivery, and FlashCell, a company developing non-integrating lentiviral delivered RNA therapeutics, have merged to create Flash Therapeutics, a new privately held gene therapy company developing gene and cell therapeutics. Financial terms of the merger were not disclosed. Flash Therapeutics will advance two complementary businesses: Development of novel RNA therapeutics based on LentiFlash, a proprietary n...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters